Bioadaptives (BDPT) Amortization of Deferred Charges (2021 - 2024)
Bioadaptives' Amortization of Deferred Charges history spans 4 years, with the latest figure at $8387.0 for Q2 2024.
- On a quarterly basis, Amortization of Deferred Charges fell 80.1% to $8387.0 in Q2 2024 year-over-year; TTM through Dec 2024 was $52592.0, a 56.01% decrease, with the full-year FY2025 number at $25132.0, down 52.21% from a year prior.
- Amortization of Deferred Charges hit $8387.0 in Q2 2024 for Bioadaptives, down from $44205.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for BDPT hit a ceiling of $118450.0 in Q4 2021 and a floor of $2680.0 in Q2 2021.
- Historically, Amortization of Deferred Charges has averaged $44876.0 across 4 years, with a median of $43178.5 in 2023.
- Biggest five-year swings in Amortization of Deferred Charges: surged 2217.35% in 2022 and later tumbled 87.84% in 2023.
- Tracing BDPT's Amortization of Deferred Charges over 4 years: stood at $118450.0 in 2021, then plummeted by 34.18% to $77965.0 in 2022, then tumbled by 65.07% to $27237.0 in 2023, then plummeted by 69.21% to $8387.0 in 2024.
- Business Quant data shows Amortization of Deferred Charges for BDPT at $8387.0 in Q2 2024, $44205.0 in Q1 2024, and $27237.0 in Q4 2023.